Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : QGEN source : Www.biospace.com save search
QIAGEN showcases latest technologies to advance cancer research at AACR Annual Meeting 2023
Published: 2023-04-14 (Crawled : 11:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: -0.3%
H: 0.34%
C: -0.21%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: -0.3%
H: 0.34%
C: -0.21%
cancer research meeting
QIAGEN receives approval for its net-zero carbon emissions target by Science Based Targets initiative (SBTi)SBTi has validated the QIAGEN targets to reach net-zero greenhouse gas (GHG) emissions
Published: 2023-03-27 (Crawled : 14:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: 0.61%
H: 0.17%
C: -0.09%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: 0.61%
H: 0.17%
C: -0.09%
approval
QIAGEN Announces Form 20-F Annual Report Filing for 2022 Results
Published: 2023-03-13 (Crawled : 13:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: 1.2%
H: 0.56%
C: -0.15%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: 1.2%
H: 0.56%
C: -0.15%
report
QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug
Published: 2023-03-09 (Crawled : 11:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: 0.35%
H: 0.37%
C: -0.78%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: 0.35%
H: 0.37%
C: -0.78%
drug diagnostic leukemia therapy
QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing
Published: 2023-03-01 (Crawled : 16:00) - biospace.com/
SOPH | $4.8 -1.03% -0.21% 0
|
|
| O: 0.0%
H: 1.92%
C: 0.77%
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: 0.24%
H: 0.13%
C: -1.67%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: 0.24%
H: 0.13%
C: -1.67%
partnership
SOPHiA GENETICS and QIAGEN Forge Partnership to Combine Strengths in Next-generation Sequencing
Published: 2023-03-01 (Crawled : 16:00) - biospace.com/
SOPH | $4.8 -1.03% -0.21% 0
|
|
| O: 0.0%
H: 1.92%
C: 0.77%
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: 0.24%
H: 0.13%
C: -1.67%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: 0.24%
H: 0.13%
C: -1.67%
partnership
QIAGEN’s tuberculosis blood test QuantiFERON-TB Gold Plus gains CE-marking under new EU IVDR framework
Published: 2023-02-14 (Crawled : 23:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: -0.27%
H: 0.6%
C: 0.08%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: -0.27%
H: 0.6%
C: 0.08%
blood test plus
QIAGEN Launches EZ2 Connect MDx Platform for Automated Sample Processing in Diagnostic Labs
Published: 2023-01-17 (Crawled : 23:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: 0.38%
H: 0.2%
C: -1.04%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: 0.38%
H: 0.2%
C: -1.04%
diagnostic platform
QIAGEN N.V. to Release Results for Q4 and Full-Year Results 2022 and Hold Webcast
Published: 2023-01-17 (Crawled : 13:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: 0.38%
H: 0.2%
C: -1.04%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: 0.38%
H: 0.2%
C: -1.04%
QIAGEN receives FDA approval for companion diagnostic to Mirati Therapeutics’ KRAZATI in non-small cell lung cancer
Published: 2022-12-13 (Crawled : 11:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: 2.13%
H: 0.3%
C: -2.2%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: 2.13%
H: 0.3%
C: -2.2%
MRTX | $58.7 -0.17% 0.34% 0
|
Health Technology
|
| O: 1.16%
H: 1.41%
C: 0.19%
fda lung diagnostic approval cancer
QIAGEN launches monkeypox test for NeuMoDx platform to fight global outbreak by boosting research and surveillance
Published: 2022-11-21 (Crawled : 00:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: 0.81%
H: 0.54%
C: -0.6%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: 0.81%
H: 0.54%
C: -0.6%
monkeypox research global test platform
QIAGEN N.V. to Release Results for Q3 2022 and Hold Webcast
Published: 2022-10-21 (Crawled : 12:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: -0.54%
H: 0.78%
C: 0.21%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: -0.54%
H: 0.78%
C: 0.21%
TwinStrand Biosciences Announces Leadership Transition
Published: 2022-10-07 (Crawled : 13:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: -0.7%
H: 0.25%
C: -2.7%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: -0.7%
H: 0.25%
C: -2.7%
QIAGEN Adds New Assays With CE-IVD Certification for NeuMoDx Integrated PCR System
Published: 2022-09-15 (Crawled : 22:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: 0.04%
H: 0.87%
C: -0.04%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: 0.04%
H: 0.87%
C: -0.04%
certification system
QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug
Published: 2022-09-14 (Crawled : 21:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: -0.22%
H: 0.07%
C: -0.51%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: -0.22%
H: 0.07%
C: -0.51%
drug disease diagnostic parkinson’s
Neuron23 and QIAGEN Announce Collaboration to Develop the First Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug
Published: 2022-09-14 (Crawled : 21:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: -0.22%
H: 0.07%
C: -0.51%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: -0.22%
H: 0.07%
C: -0.51%
drug disease collaboration parkinson's diagnostic
QIAGEN Launches Syndromic Test for QIAstat-Dx Device to Combat Global Monkeypox Health Emergency
Published: 2022-08-15 (Crawled : 23:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: -0.06%
H: 0.14%
C: -0.46%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: -0.06%
H: 0.14%
C: -0.46%
monkeypox device global test health
QIAGEN adds new biopharma products to QIAcuity digital PCR portfolio and launches Expert Custom Assay Design Service
Published: 2022-07-27 (Crawled : 07:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: -1.23%
H: 2.75%
C: 2.16%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: -1.23%
H: 2.75%
C: 2.16%
biopharma service
QIAGEN’s Clinical Decision Support Platform QCI Surpasses Three Million NGS Patient Test Cases
Published: 2022-07-19 (Crawled : 00:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: 0.39%
H: 1.92%
C: 1.55%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: 0.39%
H: 1.92%
C: 1.55%
test platform
QIAGEN N.V. to Release Results for Q2 2022 and Hold Webcast
Published: 2022-07-07 (Crawled : 11:00) - biospace.com/
QGEN | $39.47 0.61% 0.63% 3.7K
|
Health Technology
|
| O: 0.02%
H: 2.23%
C: 2.16%
QGEN | $39.47 0.61% 0.63% 1.9K
|
Health Technology
|
| O: 0.02%
H: 2.23%
C: 2.16%
Gainers vs Losers
| 58% | 42% |
Top 10 Gainers
ZCMD | $1.45 5.84% 49.63% 15M
|
Commercial Services
AULT | $0.2421 -7.7% 45.23% 16M
|
Manufacturing
XPON | News | $3.15 63.21% 33.9% 100K
|
EGOX | $0.036 12.15% 31.56% 32M
|
TIRX | $0.8 65.02% 25.95% 410K
|
VTNR 4 | $1.31 33.78% 25.82% 220K
|
Industrial Services
GDHG | $0.263 21.76% 25.34% 1.3M
|
TPET | $0.3279 -3.56% 23.57% 11M
|
n/a
HOLO | $2.95 31.7% 22.49% 37M
|
BPTH | News 0 d | $4.2 29.63% 20.98% 610K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.